Sort
10,766 grants matching “checkpoint inhibitor”
A New Immune Checkpoint Pathway in Human Bladder Cancer
$545,478Xingxing Zang · Albert Einstein College Of Medicine · R01 · FY2023 · CA
A New Immune Checkpoint Pathway in Human Bladder Cancer
$545,478Xingxing Zang · Albert Einstein College Of Medicine · R01 · FY2025 · CA
Myct1 control of the angioimmune interface
$545,472Kyunghee Choi · Washington University · R01 · FY2025 · CA
Identifying and targeting neoantigens in aggressive salivary carcinomas
$545,430Luc Gordon Trang Morris · Sloan-Kettering Inst Can Research · R01 · FY2020 · DE
Cooperation of Co-Amplified Genes in Hepatocellular Carcinoma
$545,014Devanand Sarkar · Virginia Commonwealth University · P01 · FY2024 · CA
Molecular Biology of Pediatric Tumors
$544,955Lee J. Helman · Division Of Clinical Sciences - Nci · ZIA · FY2012 · CA
Functional Relevance of Pyrimidine Sensing and Response Pathways in Tumor Metabolism and Cancer Therapy
$544,658Richard Lewis Possemato · New York University School Of Medicine · R01 · FY2024 · CA
Functional Relevance of Pyrimidine Sensing and Response Pathways in Tumor Metabolism and Cancer Therapy
$544,658Richard Lewis Possemato · New York University School Of Medicine · R01 · FY2025 · CA
Understanding how T cell intrinsic androgen receptor activity influences cell differentiation and dysfunction
$544,635Amy E Moran · Oregon Health & Science University · R37 · FY2025 · CA
Understanding how T cell intrinsic androgen receptor activity influences cell differentiation and dysfunction
$544,635Amy E Moran · Oregon Health & Science University · R37 · FY2022 · CA
Mechanisms of Nucleic Acid Enzymes - Pol Beta, HIV-1 Reverse Transcriptase and Mammalian Base Repair Enzymes
$544,588Samuel H Wilson · National Institute Of Environmental Health Sciences · ZIA · FY2018 · ES
Translation of commensal bacteria mechanism for immunotherapy
$544,219Howard C Hang · Scripps Research Institute, The · R01 · FY2022 · CA
Translation of commensal bacteria mechanism for immunotherapy
$544,219Howard C Hang · Scripps Research Institute, The · R01 · FY2023 · CA
The Role of HIF2 in Pancreatic Ductal Adenocarcinoma
$544,035Albert Koong · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Nanovaccine platforms to combat pancreatic cancer
$543,977Balaji Narasimhan · Iowa State University · U01 · FY2018 · CA
(PQ8) Predicting immune-related toxicity in the adjuvant melanoma setting with checkpoint inhibition
$543,889Iman Osman · New York University School Of Medicine · R01 · FY2019 · CA
Focused ultrasound-mediated intranasal brain drug delivery technique (FUSIN)
$543,721Hong Chen · Washington University · R01 · FY2023 · EB
NR4A1 Antagonists Inhibit Colorectal Cancer Growth and Enhance Immune Surveillance
$543,717Stephen H Safe · Texas A&M University · R01 · FY2024 · CA
Finding the optimal balance of immunotherapy efficacy and toxicity.
$543,590David Eric Gerber · Ut Southwestern Medical Center · U01 · FY2024 · AI
Plk1 as a prognostic biomarker for prostate cancer
$543,492Xiaoqi Liu · University Of Kentucky · R01 · FY2025 · CA
Immune epigenetic biomarkers of survival in glioma epidemiology
$543,240John K. Wiencke · University Of California, San Francisco · R01 · FY2021 · CA
Engineered Nanoformulation for Immune-modulation in Cancer
$543,107Rajagopal Ramesh · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2023 · CA
The Role of the Y Chromosome in Bladder Tumor Development, Growth And Progression
$543,058Dan Theodorescu · Cedars-Sinai Medical Center · P01 · FY2023 · CA
The Role of the Y Chromosome in Bladder Tumor Development, Growth And Progression
$543,058Dan Theodorescu · Cedars-Sinai Medical Center · P01 · FY2025 · CA
Non-coding RNA regulation of Myeloid Cells
$543,051Jorge Henao-Mejia · University Of Pennsylvania · R01 · FY2025 · CA